1-160128731-G-C
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_000702.4(ATP1A2):c.1097G>C(p.Gly366Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G366D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000702.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1A2 | NM_000702.4 | c.1097G>C | p.Gly366Ala | missense_variant | Exon 9 of 23 | ENST00000361216.8 | NP_000693.1 | |
ATP1A2 | XM_047421286.1 | c.206G>C | p.Gly69Ala | missense_variant | Exon 2 of 16 | XP_047277242.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1A2 | ENST00000361216.8 | c.1097G>C | p.Gly366Ala | missense_variant | Exon 9 of 23 | 1 | NM_000702.4 | ENSP00000354490.3 | ||
ATP1A2 | ENST00000392233.7 | c.1097G>C | p.Gly366Ala | missense_variant | Exon 9 of 23 | 5 | ENSP00000376066.3 | |||
ATP1A2 | ENST00000447527.1 | c.227G>C | p.Gly76Ala | missense_variant | Exon 2 of 16 | 2 | ENSP00000411705.1 | |||
ATP1A2 | ENST00000472488.5 | n.1200G>C | non_coding_transcript_exon_variant | Exon 9 of 20 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy 98 Pathogenic:1
- -
not specified Uncertain:1
A variant of uncertain significance has been identified in the ATP1A2 gene. The G366A variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The G366A variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This substitution occurs at a position that is conserved across species, and missense variants in nearby residues (V362E, T364M, T368K) have been reported in the Human Gene Mutation Database in association with hemiplegic migraine (Stenson et al., 2014), supporting the functional importance of this region of the protein. In silico analysis predicts this variant is probably damaging to the protein structure/function. However, the G366A variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at